Clinical experience with sustained-release etodolac: EULAR supplement Graham Hughes EditorialNotes Pages: S1 - S2
Worldwide experience with etodolac (Lodine®) 300 mg b.i.d. in the treatment of osteoarthritis P. Bacon OriginalPaper Pages: S7 - S12
A comparison of the efficacy of etodolac SR (Lodine® SR) and etodolac (Lodine®) in patients with rheumatoid arthritis or osteoarthritis R. L. Dreiser OriginalPaper Pages: S13 - S18
Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee F. Porzio OriginalPaper Pages: S19 - S24
Meta-analysis of two double-blind comparative studies with the sustained-release form of etodolac in rheumatoid arthritis F. Porzio OriginalPaper Pages: S25 - S30